Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	-	FMO3 FMO4 RNLS CHDH CFAP61	6.92e-06	56	89	5	3.50.50.60
Domain	FAD/NAD-binding_dom	FMO3 FMO4 RNLS CHDH CFAP61	7.56e-06	57	89	5	IPR023753
Domain	FMO-like	FMO3 FMO4	2.22e-04	5	89	2	PF00743
Domain	Flavin_mOase	FMO3 FMO4	2.22e-04	5	89	2	IPR000960
Domain	Flavin_mOase-like	FMO3 FMO4	2.22e-04	5	89	2	IPR020946
Domain	DiMe-aniline_mOase	FMO3 FMO4	2.22e-04	5	89	2	IPR012143
Domain	Acid_Pase_AS	ACP4 PPIP5K2	3.33e-04	6	89	2	IPR033379
Domain	HIS_ACID_PHOSPHAT_2	ACP4 PPIP5K2	4.64e-04	7	89	2	PS00778
Domain	HIS_ACID_PHOSPHAT_1	ACP4 PPIP5K2	4.64e-04	7	89	2	PS00616
Domain	His_Pase_clade-2	ACP4 PPIP5K2	6.17e-04	8	89	2	IPR000560
Domain	His_Phos_2	ACP4 PPIP5K2	6.17e-04	8	89	2	PF00328
Domain	His_PPase_superfam	ACP4 PPIP5K2	4.03e-03	20	89	2	IPR029033
Domain	-	ACP4 PPIP5K2	4.03e-03	20	89	2	3.40.50.1240
Pubmed	Fgf and Esrrb integrate epigenetic and transcriptional networks that regulate self-renewal of trophoblast stem cells.	BPTF PTPN14 FRG1 POLR2A ZNF516 POLR1B ASCC3 SFMBT2	2.28e-08	177	91	8	26206133
Pubmed	Co-transcriptional splicing regulates 3' end cleavage during mammalian erythropoiesis.	POLR2A HBB	6.77e-06	2	91	2	33440169
Pubmed	Quantification and cellular localization of expression in human skin of genes encoding flavin-containing monooxygenases and cytochromes P450.	FMO3 FMO4	2.03e-05	3	91	2	11551524
Pubmed	Human 5' --> 3' exonuclease Xrn2 promotes transcription termination at co-transcriptional cleavage sites.	POLR2A HBB	2.03e-05	3	91	2	15565158
Pubmed	Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy.	METAP1 FMO3 FMO4 ADH1B	2.79e-05	66	91	4	19898482
Pubmed	Paraspeckle Protein NONO Promotes TAZ Phase Separation in the Nucleus to Drive the Oncogenic Transcriptional Program.	POLR2A TAFAZZIN	4.05e-05	4	91	2	34716691
Pubmed	Association analysis among polymorphisms of the various genes and chronic alcoholic pancreatitis.	NQO2 ADH1B	4.05e-05	4	91	2	18336668
Pubmed	The mammalian flavin-containing monooxygenases: molecular characterization and regulation of expression.	FMO3 FMO4	6.74e-05	5	91	2	8128486
Pubmed	Flavin-Containing Monooxygenase 1 Catalyzes the Production of Taurine from Hypotaurine.	FMO3 FMO4	6.74e-05	5	91	2	32156684
Pubmed	CDK8 and CDK19 act redundantly to control the CFTR pathway in the intestinal epithelium.	POLR2A CDK7	6.74e-05	5	91	2	36545778
Pubmed	A nomenclature for the mammalian flavin-containing monooxygenase gene family based on amino acid sequence identities.	FMO3 FMO4	6.74e-05	5	91	2	8311461
Pubmed	Retroviral cyclin enhances cyclin-dependent kinase-8 activity.	POLR2A CDK7	6.74e-05	5	91	2	22379099
Pubmed	Purification and characterization of the human elongator complex.	POLR2A ELP1	6.74e-05	5	91	2	11714725
Pubmed	Three cyclin-dependent kinases preferentially phosphorylate different parts of the C-terminal domain of the large subunit of RNA polymerase II.	POLR2A CDK7	1.01e-04	6	91	2	15009212
Pubmed	Identification of novel variants of the flavin-containing monooxygenase gene family in African Americans.	FMO3 FMO4	1.01e-04	6	91	2	12527699
Pubmed	hnRNP U inhibits carboxy-terminal domain phosphorylation by TFIIH and represses RNA polymerase II elongation.	POLR2A CDK7	1.01e-04	6	91	2	10490622
Pubmed	Three RNA polymerase II carboxyl-terminal domain kinases display distinct substrate preferences.	POLR2A CDK7	1.01e-04	6	91	2	11278802
Pubmed	The crystal structure of human CDK7 and its protein recognition properties.	POLR2A CDK7	1.01e-04	6	91	2	15530371
Pubmed	A genome-wide association scan on the levels of markers of inflammation in Sardinians reveals associations that underpin its complex regulation.	CR1 HBB	1.01e-04	6	91	2	22291609
Pubmed	Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.	INTS14 POGLUT1 MDN1 RNLS SIGLEC9 ELP1 TIMELESS EMC8 REV3L FASTKD3 ADCY7 ADH1B	1.39e-04	1293	91	12	15342556
Pubmed	Proximity among distant regulatory elements at the beta-globin locus requires GATA-1 and FOG-1.	POLR2A HBB	1.41e-04	7	91	2	15694345
Pubmed	Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	PCDH18 SFMBT2 PPP4R4 EPG5	1.47e-04	101	91	4	10997877
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ARG2 BPTF NID2 INTS14 PTPN14 POLR2A REV3L ASCC3 UNC80 ZNF518A BRWD1	1.60e-04	1116	91	11	31753913
Pubmed	The human (PEDB) and mouse (mPEDB) Prostate Expression Databases.	ARG2 BPTF GLB1L3 ADH1B	1.78e-04	106	91	4	11752298
Pubmed	Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context.	ARG2 TMEM141 PANK2 PDE12 OSGEPL1 CHDH MRPL13 PNPLA8 FASTKD3 TRUB2 TAFAZZIN	1.87e-04	1136	91	11	34800366
Pubmed	CDKN1C negatively regulates RNA polymerase II C-terminal domain phosphorylation in an E2F1-dependent manner.	POLR2A CDK7	1.88e-04	8	91	2	20106982
Pubmed	Cyclin-dependent kinase control of the initiation-to-elongation switch of RNA polymerase II.	POLR2A CDK7	1.88e-04	8	91	2	23064645
Pubmed	Dichotomous but stringent substrate selection by the dual-function Cdk7 complex revealed by chemical genetics.	POLR2A CDK7	1.88e-04	8	91	2	16327805
Pubmed	BRCA1 can modulate RNA polymerase II carboxy-terminal domain phosphorylation levels.	POLR2A CDK7	2.41e-04	9	91	2	15282296
Pubmed	TFIID component TAF7 functionally interacts with both TFIIH and P-TEFb.	POLR2A CDK7	2.41e-04	9	91	2	18391197
Pubmed	A uniform procedure for the purification of CDK7/CycH/MAT1, CDK8/CycC and CDK9/CycT1.	POLR2A CDK7	2.41e-04	9	91	2	15328539
Pubmed	The Role of XPB/Ssl2 dsDNA Translocase Processivity in Transcription Start-site Scanning.	POLR2A CDK7	2.41e-04	9	91	2	33453189
Pubmed	The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.	PDE12 DCTN5 ELP1 NEURL4 CDK7	2.44e-04	212	91	5	33853758
Pubmed	Identification of novel candidate genes for type 2 diabetes from a genome-wide association scan in the Old Order Amish: evidence for replication from diabetes-related quantitative traits and from independent populations.	RNLS ADAM12	3.01e-04	10	91	2	17846126
Pubmed	Evolutionary divergence of the mouse and human Lgn1/SMA repeat structures.	NAIP CDK7	3.01e-04	10	91	2	10708519
Pubmed	A novel RNA polymerase II C-terminal domain phosphatase that preferentially dephosphorylates serine 5.	POLR2A CDK7	3.01e-04	10	91	2	12721286
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	MDN1 ZNF451 ZNF516 REV3L ZNF518A	3.02e-04	222	91	5	37071664
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	GALNT15 MDN1 DCTN5 SLC35F6 TMEM185A ELP1 TIMELESS CFAP61 AGAP9 TRIM29 TRUB2	4.00e-04	1242	91	11	30973865
Pubmed	Inhibition of RIF1 by SCAI Allows BRCA1-Mediated Repair.	POLR2A REV3L	4.39e-04	12	91	2	28700933
Pubmed	Human cyclin-dependent kinase-activating kinase exists in three distinct complexes.	POLR2A CDK7	4.39e-04	12	91	2	8692842
Pubmed	Interaction of elongation factors TFIIS and elongin A with a human RNA polymerase II holoenzyme capable of promoter-specific initiation and responsive to transcriptional activators.	POLR2A CDK7	4.39e-04	12	91	2	9305922
Pubmed	Expression pattern of transcriptional enhanced associate domain family member 1 (Tead1) in developing mouse molar tooth.	CCN2 TAFAZZIN	5.18e-04	13	91	2	33984529
Pubmed	A functional interaction between the survival motor neuron complex and RNA polymerase II.	POLR2A GEMIN4	5.18e-04	13	91	2	11149922
Pubmed	FACT facilitates chromatin transcription by RNA polymerases I and III.	POLR2A POLR1B	5.18e-04	13	91	2	19214185
Pubmed	The structural biology of HIV-1: mechanistic and therapeutic insights.	POLR2A APOBEC3G	5.18e-04	13	91	2	22421880
Pubmed	Several genes contribute to the production of autoreactive B and T cells in the murine lupus susceptibility locus Sle1c.	PTPN14 CR1	5.18e-04	13	91	2	16002709
Pubmed	YAP and TAZ maintain PROX1 expression in the developing lymphatic and lymphovenous valves in response to VEGF-C signaling.	CCN2 TAFAZZIN	5.18e-04	13	91	2	33060128
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	ARG2 PTPN14 PDE12 MDN1 GEMIN4 MRPL13 ELP1 PNPLA8 EMC8 FASTKD3 NEURL4 TRUB2	5.23e-04	1496	91	12	32877691
Pubmed	HIV-1 Tat-associated RNA polymerase C-terminal domain kinase, CDK2, phosphorylates CDK7 and stimulates Tat-mediated transcription.	POLR2A CDK7	6.95e-04	15	91	2	12049628
Pubmed	HIV-1 reverse transcription.	POLR2A APOBEC3G	6.95e-04	15	91	2	23028129
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	BPTF POLR2A ZNF516 ARHGAP29 SLITRK3 UNC80	8.41e-04	420	91	6	28065597
Pubmed	Hedgehog-Activated Fat4 and PCP Pathways Mediate Mesenchymal Cell Clustering and Villus Formation in Gut Development.	POLR2A CCN2	8.98e-04	17	91	2	32155439
Pubmed	CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA.	POLR2A CDK7	8.98e-04	17	91	2	10958691
Pubmed	The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription.	POLR2A CDK7	8.98e-04	17	91	2	16109376
Pubmed	Functional proteomics mapping of a human signaling pathway.	METAP1 NID2 ZNF451 ASCC3 TRIM29 ZNF518A EPG5	9.33e-04	591	91	7	15231748
Pubmed	WNT/β-catenin signaling plays a crucial role in myoblast fusion through regulation of nephrin expression during development.	MYMK ADAM12	1.01e-03	18	91	2	30389854
Pubmed	CA150, a nuclear protein associated with the RNA polymerase II holoenzyme, is involved in Tat-activated human immunodeficiency virus type 1 transcription.	POLR2A CDK7	1.01e-03	18	91	2	9315662
Pubmed	Rrn3 becomes inactivated in the process of ribosomal DNA transcription.	POLR1B CDK7	1.12e-03	19	91	2	12646563
Pubmed	GGA2 and RAB13 promote activity-dependent β1-integrin recycling.	ZBED6 ARHGAP29	1.12e-03	19	91	2	31076515
Pubmed	Transcription factor TFIIH components enhance the GR coactivator activity but not the cell cycle-arresting activity of the human immunodeficiency virus type-1 protein Vpr.	POLR2A CDK7	1.12e-03	19	91	2	12379213
Pubmed	DNA cloning using in vitro site-specific recombination.	GALNT15 INTS14 PNPLA8 ASCC3 HBB PGGT1B TAFAZZIN CDK7	1.14e-03	794	91	8	11076863
Pubmed	Immunoaffinity purification and functional characterization of human transcription factor IIH and RNA polymerase II from clonal cell lines that conditionally express epitope-tagged subunits of the multiprotein complexes.	POLR2A CDK7	1.38e-03	21	91	2	9852112
Pubmed	The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II.	POLR2A CDK7	1.38e-03	21	91	2	9334327
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	MDN1 POT1 ZNF516 ELP1 REV3L CSMD2 PPP4R4	1.45e-03	638	91	7	31182584
Pubmed	Cloning and functional characterization of PTRF, a novel protein which induces dissociation of paused ternary transcription complexes.	POLR1B CDK7	1.51e-03	22	91	2	9582279
Pubmed	Transcriptional control: Tat cofactors and transcriptional elongation.	POLR2A CDK7	1.65e-03	23	91	2	9651670
Pubmed	Direct evidence that HIV-1 Tat stimulates RNA polymerase II carboxyl-terminal domain hyperphosphorylation during transcriptional elongation.	POLR2A CDK7	1.65e-03	23	91	2	10438593
Pubmed	Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription.	POLR2A CDK7	1.65e-03	23	91	2	10866664
Pubmed	Multiple interactions between RNA polymerase I, TIF-IA and TAF(I) subunits regulate preinitiation complex assembly at the ribosomal gene promoter.	POLR1B CDK7	1.65e-03	23	91	2	12393749
Pubmed	A human primary T-lymphocyte-derived human immunodeficiency virus type 1 Tat-associated kinase phosphorylates the C-terminal domain of RNA polymerase II and induces CAK activity.	POLR2A CDK7	1.65e-03	23	91	2	9311822
Pubmed	Tat, Tat-associated kinase, and transcription.	POLR2A CDK7	1.65e-03	23	91	2	9570510
Pubmed	An Interaction Landscape of Ubiquitin Signaling.	PDE12 ZNF451 ARHGAP29 ASCC3 NEURL4 CDK7	1.68e-03	481	91	6	28190767
Pubmed	Selective recognition of viral promoters by host cell transcription complexes: challenges and opportunities to control latency.	POLR2A CDK7	1.80e-03	24	91	2	23827503
Pubmed	The Tat/TAR-dependent phosphorylation of RNA polymerase II C-terminal domain stimulates cotranscriptional capping of HIV-1 mRNA.	POLR2A CDK7	1.80e-03	24	91	2	14569024
Pubmed	Piezo1/2 mediate mechanotransduction essential for bone formation through concerted activation of NFAT-YAP1-ß-catenin.	POLR2A CCN2	1.80e-03	24	91	2	32186512
Pubmed	Tat-associated kinase (P-TEFb): a component of transcription preinitiation and elongation complexes.	POLR2A CDK7	1.80e-03	24	91	2	10066804
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	METAP1 MDN1 DCTN5 ZBED6 FRG1 POLR2A SLC35F6 GEMIN4 POLR1B ASCC3 CDK7	1.82e-03	1497	91	11	31527615
Pubmed	Purification of a Tat-associated kinase reveals a TFIIH complex that modulates HIV-1 transcription.	POLR2A CDK7	1.95e-03	25	91	2	9184228
Pubmed	Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain.	POLR2A CDK7	1.95e-03	25	91	2	8934526
Pubmed	Isolation and characterization of a human cDNA for mRNA 5'-capping enzyme.	POLR2A CDK7	1.95e-03	25	91	2	9512541
Pubmed	Cloning and characterization of three human cDNAs encoding mRNA (guanine-7-)-methyltransferase, an mRNA cap methylase.	POLR2A CDK7	1.95e-03	25	91	2	9790902
Pubmed	Homeostatic and tumourigenic activity of SOX2+ pituitary stem cells is controlled by the LATS/YAP/TAZ cascade.	CCN2 TAFAZZIN	1.95e-03	25	91	2	30912742
Pubmed	Platelet proteome analysis reveals integrin-dependent aggregation defects in patients with myelodysplastic syndromes.	METAP1 HBB	2.11e-03	26	91	2	23382103
Pubmed	Lats1 and Lats2 are required for the maintenance of multipotency in the Müllerian duct mesenchyme.	CCN2 TAFAZZIN	2.28e-03	27	91	2	31575647
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PCNX2 MDN1 SZT2 POLR2A ZNF516 RTTN UNKL REV3L ADCY7	2.44e-03	1105	91	9	35748872
Pubmed	Elf5-centered transcription factor hub controls trophoblast stem cell self-renewal and differentiation through stoichiometry-sensitive shifts in target gene networks.	BPTF INTS14 POLR2A	2.47e-03	102	91	3	26584622
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	PDE12 DCTN5 POLR2A ELP1 POLR1B TIMELESS ASCC3	2.52e-03	704	91	7	29955894
Pubmed	PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation.	MDN1 POLR2A GEMIN4 ASCC3	2.58e-03	217	91	4	31685992
Cytoband	4q23	METAP1 C4orf54 ADH1B	8.38e-06	20	91	3	4q23
Cytoband	Ensembl 112 genes in cytogenetic band chr4q23	METAP1 C4orf54 ADH1B	5.57e-05	37	91	3	chr4q23
Cytoband	1q24.3	FMO3 FMO4	7.21e-04	20	91	2	1q24.3
Coexpression	GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_DN	DCTN5 MRPL13 APOBEC3G TIMELESS ASCC3 GFI1 CDK7	6.38e-06	200	91	7	M5590
ToppCell	IIH-CD8-antiviral_CD4\|IIH / Condition, Cell_class and T cell subcluster	TMEM141 RTTN KLHL42 LCAT GFI1 CDK7	1.72e-06	177	91	6	fe73608c40701eca88b260aeb5c0640d7bee72ba
ToppCell	E17.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CCN2 LCAT ZNF385C SFMBT2 UNC80	2.52e-05	169	91	5	58e22f9119240664515fe91ca53812611a8f17d6
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	POGLUT1 FMO3 CCN2 PCDH18 ADH1B	3.07e-05	176	91	5	fcf324e6402819683f95e0dd94bf1f777c7f4c76
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10\|TCGA-Colorectal / Sample_Type by Project: Shred V9	SIGLEC9 NAIP CSMD2 CR1 ADAM12	3.32e-05	179	91	5	cc079ba015326dccde955c5eafa3e4a2e40de192
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Macroglial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHDH SLITRK3 ADAM12 UNC80 PPP4R4	4.20e-05	188	91	5	c2101ded71fb16b8ddbc1f883911b1ed2a533ffc
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-Schwann_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHDH SLITRK3 ADAM12 UNC80 PPP4R4	4.20e-05	188	91	5	3b8b9161f0fdcbde302ce5b4c0bc874628211109
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NID2 FMO3 ADAM12 PCDH18 ADH1B	4.53e-05	191	91	5	39092a0aff8097617820c59f5fea9ee2bb4f63a2
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NID2 FMO3 ADAM12 PCDH18 ADH1B	4.53e-05	191	91	5	ee5f1b1c59029c46cbb1a00935c03b9317bb9da9
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-A\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NID2 FMO3 ARHGAP29 CCN2 PCDH18	4.64e-05	192	91	5	fee99ca7e658963acf968aa724ef8c96cfc00a5d
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NID2 FMO3 ADAM12 PCDH18 ADH1B	4.87e-05	194	91	5	02b8102be9414d6964cd71019613edff6d88b893
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FMO3 CCN2 ADAM12 PCDH18 ADH1B	4.99e-05	195	91	5	cad6563cc51d212554152c727fc2c249c6a07e4d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FMO3 CCN2 ADAM12 PCDH18 ADH1B	4.99e-05	195	91	5	783bfa8110161cbd6def50ce849cae676c39c458
ToppCell	Fibroblasts-DKK3+_Fibroblasts\|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	GALNT15 PTPN14 TRIM29 ADAM12 ADCY7	5.12e-05	196	91	5	24d64b67aa9b0e8215ad06f9101c1314b3483620
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NID2 ARHGAP29 CCN2 ADAM12 PCDH18	5.24e-05	197	91	5	983502a99e6d59bb36225b0246a9990604de1a01
ToppCell	COVID-19-kidney-Fibroblast-2\|kidney / Disease (COVID-19 only), tissue and cell type	NID2 FMO3 ADAM12 PCDH18 ADH1B	5.37e-05	198	91	5	ca26ca460856b1faaa3e83766da6abdf63af2b51
ToppCell	Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	RNLS POLR1B CSMD2 FASTKD3 ADH1B	5.37e-05	198	91	5	0cd930e374c2c48d1991b51c025f9801b22ecee7
ToppCell	Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	RNLS POLR1B CSMD2 FASTKD3 ADH1B	5.37e-05	198	91	5	e0df6d6ff2a9c41d813f84a2a5ee7cb5f6fc3e30
ToppCell	metastatic_Brain-Fibroblasts-FB-like_cells\|metastatic_Brain / Location, Cell class and cell subclass	NID2 FMO3 CCN2 ADAM12 ADH1B	5.50e-05	199	91	5	12133087eae9f0e9b6c13a71e8187117768e64ce
ToppCell	Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	FMO3 INPP5A KLHL42 PCDH18 ADH1B	5.50e-05	199	91	5	e9009eee7f77b9c9917f8e0e723001d9e76eb553
ToppCell	COVID-19-kidney-Fibroblast-1\|kidney / Disease (COVID-19 only), tissue and cell type	NID2 FMO3 REV3L PCDH18 ADH1B	5.50e-05	199	91	5	9503646ff1ad248181146ce767e9d12e882ec3bd
ToppCell	cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	GALNT15 NID2 FMO3 PCDH18 ADH1B	5.63e-05	200	91	5	44317fbf4d1480a37b50ab2777bf1a3e4fc0c05f
ToppCell	cellseq2-Mesenchymal-Fibroblastic\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	GALNT15 NID2 FMO3 PCDH18 ADH1B	5.63e-05	200	91	5	1c10597edd532bf172ca09870a937d35e2585081
ToppCell	cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	GALNT15 NID2 FMO3 PCDH18 ADH1B	5.63e-05	200	91	5	440dda48b09c6a8581b7ca634b0d67f1ecacf65e
Disease	Malaria, Falciparum	CR1 HBB	5.50e-05	4	90	2	C0024535
Disease	Malignant neoplasm of breast	DPAGT1 NID2 PTPN14 ARHGAP29 MRPL13 ELP1 TIMELESS FASTKD3 TRIM29 NQO2 ADAM12 EPG5	1.02e-04	1074	90	12	C0006142
Disease	metabolite measurement	BPTF FMO3 FMO4 GLB1L3 REV3L HBB NQO2 ADH1B	3.17e-04	560	90	8	EFO_0004725
Disease	Abruptio Placentae	GALNT15 ADAM12	5.95e-04	12	90	2	EFO_1001754
Disease	alcohol dependence measurement	METAP1 BPTF ADH1B	6.42e-04	55	90	3	EFO_0007835
Disease	periprosthetic osteolysis, disease progression measurement	INPP5A SFMBT2	9.41e-04	15	90	2	EFO_0008336, EFO_0009761
Disease	–	CR1 HBB	1.07e-03	16	90	2	611162
Disease	Malaria, susceptibility to	CR1 HBB	1.07e-03	16	90	2	cv:C1970028
Disease	Malaria	CR1 HBB	1.69e-03	20	90	2	C0024530
Disease	brain age measurement	KLHL38 INPP5A	1.69e-03	20	90	2	EFO_0010602
Disease	sex interaction measurement, cerebral amyloid angiopathy	GALNT15 ADH1B	1.86e-03	21	90	2	EFO_0006790, EFO_0008343
Disease	malaria (is_implicated_in)	CR1 HBB	2.43e-03	24	90	2	DOID:12365 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
KHLLAFHFNGAAPLS	ZNF385C	31	Q66K41
DHKRFHPDCGFLLNK	NAIP	116	Q13075
FIRHPGHCLQDGKSF	EPG5	2546	Q9HCE0
QLLHECFDLGPFHGL	CFAP61	251	Q8NHU2
CQAHGFPKILGVLTH	AGAP9	66	Q5VTM2
LGCHLKDFGDLSFTP	ARG2	61	P78540
RFHHGDTLKFECQPA	CSMD2	536	Q7Z408
FLCNQAPHKHGFLEG	APOBEC3G	241	Q9HC16
FTCRGKPIHHFLGTS	ADH1B	131	P00325
FQPCQAHLGHLGKGL	ADAM12	761	O43184
LQLHPVGCGTAFDFH	DNAI1	491	Q9UI46
HHGIFPKVLRAAGQC	DNHD1	2051	Q96M86
IFLCGNLTGAFHKHQ	ADCY7	186	P51828
HLAHKFCLTPAGEFK	BPTF	876	Q12830
RGKTNHPLHCAFLEA	CHDH	191	Q8NE62
LNGEIVCKLHGHGHF	PCDH18	391	Q9HCL0
KHLFLCGSLVFHVGD	POGLUT1	281	Q8NBL1
PPLHHAKNCDFSFTG	OSGEPL1	241	Q9H4B0
CSFGESVKLLHPFHE	MDN1	5426	Q9NU22
PGLNHFKGKCFHSRD	FMO3	161	P31513
YCGHGIHKLFHTAPN	METAP1	291	P53582
HSRKHTGFKPFGCDL	GFI1	386	Q99684
GKPHFTLEGHKFLIF	GLB1L3	76	Q8NCI6
KEIHFGSPQHLCFAV	GALNT15	551	Q8N3T1
QCKAFPHHEFVALIG	DPAGT1	86	Q9H3H5
KPGHLPHLLSCNAAF	PCNX2	1476	A6NKB5
PHFMALHCQEFGGKN	INPP5A	46	Q14642
LKLHCTPGDGQRFGH	PDE12	246	Q6L8Q7
CTGHFLNPHLPLEAF	FMO4	146	P31512
NGLLHGHFTLPFLKD	ELP1	271	O95163
PLQHGTLHFCGFKVL	NQO2	171	P16083
GLHCHLNKTSLFGEG	PARP16	166	Q8N5Y8
CGRKGNLHFIRFPTH	PANK2	276	Q9BZ23
LGHFIPLQCHGKSDF	NID2	1046	Q14112
ACLGFEFRKHLGNPA	ACP4	311	Q9BZG2
ICGHQKLPGKIHLFG	ARHGAP29	656	Q52LW3
HALDNGLFTLGAPHK	FRG1	71	Q14331
GHCQAPDHFLFAKLK	CR1	491	P17927
GHCQAPDHFLFAKLK	CR1	941	P17927
HPNIIGLLDAFGHKS	CDK7	71	P50613
PHKGLFCHFGSPANR	CCN2	76	P29279
PFHAVLKCGHLTADV	INTS14	211	Q96SY0
HLRTHTGEKPFACGA	GLI4	341	P10075
SHGHLLIFGFGCSKP	BRWD1	536	Q9NSI6
FSKGVAFFPLHIGDH	DCTN5	76	Q9BTE1
GKPVFLIGHSLGCLH	LCAT	196	P04180
LHGAKYPHCAVNGLL	EMC8	16	O43402
LVCVLAHHFGKEFTP	HBB	111	P68871
FPSDHHCLFLSLKPG	C4orf54	126	D6RIA3
LLFHPNCGQKAAITH	NEURL4	521	Q96JN8
CYSPSNHGLHIGILK	PNPLA8	71	Q9NP80
HPDALHAYFGICGLS	PGGT1B	316	P53609
SSLCNGIHFLLHPKV	RTTN	656	Q86VV8
GGDTCVHEIPFHFDL	SZT2	981	Q5T011
QASFCELHLKPHLEG	TRIM29	191	Q14134
HLGKLCHGLYGIFTP	PPP4R4	316	Q6NUP7
LVHKLDGHNAFSCIP	TMEM185A	231	Q8NFB2
CSRQPEPFGVKFHHA	FASTKD3	46	Q14CZ7
FPQLFLFHTVHCAGP	GNRHR2	81	Q96P88
VGDITCETPFHFHGK	SLITRK3	256	O94933
PFLIQGTIHHYGCKQ	POT1	491	Q9NUX5
PVKDNHGNCVHLGIF	PTPN14	221	Q15678
FHLLGDPHTKNCTLS	SIGLEC9	91	Q9Y336
LPELIHACGGKDHVF	ASCC3	1996	Q8N3C0
CFGNLPKEPSFRHHF	TIMELESS	96	Q9UNS1
IECGKSFHQPGHLRA	ZNF516	1101	Q92618
KHCFLQKPSVAHFGS	ZNF451	811	Q9Y4E5
LPAHLSPHMFGGFKC	ZNRF2	146	Q8NHG8
IFLGLCAENHFHPGN	ZNF343	131	Q6P1L6
VCGKPFHSLSSFQVH	ZNF136	256	P52737
KRLGCHSFDDHLSPN	UNC80	1151	Q8N2C7
FGATPAGQKTCLHLH	REV3L	41	O60673
AGQKTCLHLHGIFPY	REV3L	46	O60673
KELHSHFFSLGKCVP	TAFAZZIN	106	Q16635
LHHKPFLACGGDGFT	RNLS	306	Q5VYX0
CPGHFGHIELAKPVF	POLR2A	81	P24928
HKQHGAQEAPPFCFR	SFMBT2	386	Q5VUG0
KHLHIHSGTFPFTCQ	ZNF518A	251	Q6AHZ1
GLHKPVYHALSDCGD	MRPL13	41	Q9BYD1
CGGSKEHSFQHPFLQ	SLC35F6	36	Q8N357
CVKNGLHCAFAHGPL	UNKL	131	Q9H9P5
KHPGLGEYAACQSHA	TMEM141	16	Q96I45
HAIKDGGFTHVPCFL	ZBED6	571	P86452
FHGALKEGPSSLFIH	TMEM72	171	A0PK05
INHPLVCGPAFAHLK	TRUB2	76	O95900
RFHVELHFSPGAKGC	PPIP5K2	886	O43314
FHPKDHNIFLCGGFS	WDR25	341	Q64LD2
KSAALHGLCHDATPF	POLR1B	936	Q9H9Y6
ECGKAFNHPATLFSH	ZNF506	261	Q5JVG8
HGGFLLAEQLFHPKA	GEMIN4	16	P57678
QGQLPHKLFDHACLT	KLHL38	556	Q2WGJ6
HFHEVLCKPQFHLLG	KLHL42	156	Q9P2K6
LFFVALHHACNGPGL	MYMK	41	A6NI61